Cited by 522Mental Health Treatment and AccessBipolar Disorder and TreatmentTreatment of Major Depression

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature

Open access

Waraich, Paul, Goldner, Elliot M, Somers, Julian M, Hsu, Lorena·2004·The Canadian Journal of Psychiatry

Open this paper in CoChat — free account Open PDF

Abstract

This is the second in a series of papers that present systematic reviews of the prevalence and incidence of psychiatric disorders drawn from studies published in English literature in the years 1980 to 2000. The series discusses the implications of these epidemiologic findings to mental health policy and practice. Objective: To present the results of a systematic review of literature published between January 1, 1980, and December 31, 2000, that reports findings on the prevalence and incidence of mood disorders in both general population and primary care settings. Method: We conducted a literature search of epidemiologic studies of mood disorders, using Medline and HealthSTAR databases and canvassing English-language publications. Eligible publications were restricted to studies that examined subjects aged at least 15 years and over. We used a set of predetermined inclusion and exclusion criteria to identify relevant studies. We extracted and analyzed prevalence and incidence data for heterogeneity. Results: Of general population studies, a total of 18 prevalence and 5 incidence studies met eligibility criteria. We found heterogeneity across 1-year and lifetime prevalence of major depressive disorder (MDD), dysthymic disorder, and bipolar I disorder. The corresponding pooled rates for 1-year prevalence were 4.1 per 100, 2.0 per 100, and 0.72 per 100, respectively. For lifetime prevalence, the corresponding pooled rates were 6.7 per 100, 3.6 per 100, and 0.8 per 100, respectively. Significant variation was observed among 1-year incidence rates of MDD, with a corresponding pooled rate of 2.9 per 100. Conclusions: The prevalence of mood disorders reported in high-quality studies is generally lower than rates commonly reported in the general psychiatric literature. When controlled for common methodological confounds, variation in prevalence rates persists across studies and deserves continued study. Methodological variation among studies that have examined the prevalence of depression in primary health care services is so large that comparative analyses cannot be achieved.

Integrity signals

Registry

Crossref · 10.1177/070674370404900208

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States: Results From the National Comorbidity Survey
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 9,034
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence
Kessler, R. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90026-g · Cited by 2,207 · cited 1×
“The results of 2 studies reporting only 1-year age-specific rates are not reported here (35,44).”
Background
The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485
Methods in observational epidemiology
Leck, I. M. (1987) · Journal of Epidemiology & Community Health · doi:10.1136/jech.41.3.263-a · Cited by 1,289
Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)
Bijl, R. V., Ravelli, A., & van Zessen, G. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050098 · Cited by 1,216 · cited 6×
“8 per 100 in the Netherlands (18), which is a variation of 12-fold.”
BackgroundResultInfluential
Revised Prevalence Estimates of Mental Disorders in the United States
Narrow, W. E., Rae, D. S., Robins, L. N., & Regier, D. A. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.2.115 · Cited by 807
Increasing Rates of Depression
Klerman, G. L. (1989) · JAMA · doi:10.1001/jama.1989.03420150079041 · Cited by 787

Show all 83 references

Research works printed but not linked: 15

World Health Organization, 1992, International statistical classification of diseases and related health problems. 10th rev
Lemelin J, 1994, Why do we miss the diagnosis? Can Fam Physician, 40, 104
Murray CJL, 1996, The global burden of disease
Eddy DM, 1992, Meta-analysis by the confidence interval method. The statistical synthesis of evidence
Bourdon KH, 1992, Public Health Reports, 107, 663
Morosini PL, 1992, Annali dell Istituto Superiore di Sanita, 28, 547
10.1177/000486748902300319 · DOI
Patten SB, 2000, CMAJ, 163, 714
Wacker HR, 1992, Int J Methods Psychiatr Res, 2, 91
10.1177/000486748902300318 · DOI
Shen Y, 1981, Chin Med J, 94, 153
Zung WWK, 1983, J Clin Psychiatry, 44, 365
Rowe MG, 1995, J Fam Pract, 41, 551
Zung WWK, 1983, J Clin Psychiatry, 44, 3
Ornstein S, 2000, J Fam Pract, 49, 68

Sorted by citations

Items 101–200 of 522

Long-Term Results of a Web-Based Guided Self-Help Intervention for Employees With Depressive Symptoms: Randomized Controlled Trial
Geraedts, A. S., Kleiboer, A. M., Twisk, J., Wiezer, N. M., van Mechelen, W., & Cuijpers, P. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3539 · Cited by 89
“Depressive disorders are highly prevalent in the general [1-3] and working [4,5] populations and lead to excessive costs [6,7].”
Depressive symptoms and their association with social determinants and chronic diseases in middle-aged and elderly Chinese people
Liu, Q., Cai, H., Yang, L. H., Xiang, Y.-B., Yang, G., Li, H., Gao, Y.-T., Zheng, W., Susser, E., & Shu, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-22175-2 · Cited by 89
“These questions were: (1) I felt that I could not get rid of depressed emotion even with help from my relatives and friends; (2) I felt I was in a blue mood; (3) I was happy; (4) I cried; (5) I felt I couldn’t go on with the routine of living; (6) I felt that so many words should be said, but I couldn’t find the appro…”
Neuroimaging insights into the link between depression and Insomnia: A systematic review
Bagherzadeh‐Azbari, S., Khazaie, H., Zarei, M., Spiegelhalder, K., Walter, M., Leerssen, J., Someren, E. J. W. V., Sepehry, A. A., & Tahmasian, M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.089 · Cited by 89
Supportive Care: Integration of Patient-Centered Kidney Care to Manage Symptoms and Geriatric Syndromes
Davison, S. N., & Jassal, S. V. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01050116 · Cited by 92
“This is compared with the lifetime risk of depression in the general population of approximately 7% (44).”
Background
Primary care teams’ experiences of delivering mental health care during the COVID-19 pandemic: a qualitative study
Ashcroft, R., Donnelly, C. A., Dancey, M., Gill, S., Lam, S., Kourgiantakis, T., Adamson, K., Verrilli, D., Dolovich, L. R., Kirvan, A., et al. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01496-8 · Cited by 94
Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting
Brunoni, A. R., Teng, C. T., Correa, C. F., Imamura, M., Brasil-Neto, J. P., Boëchat‐Barros, R., Rosa, M. A., Caramelli, P., Cohen, R. B., Porto, J. A. D., et al. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000300021 · Cited by 86
Prevalence of Mental Disorders in the WHO Eastern Mediterranean Region: A Systematic Review and Meta-Analysis
Zuberi, A., Waqas, A., Naveed, S., Hossain, M. M., Rahman, A., Saeed, K., & Fuhr, D. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.665019 · Cited by 88
“This criterion has been used previously and ensures adequate statistical power to provide precise, reliable and stable prevalence estimates of the general population (2, 12, 13).”
BackgroundMethod
The Association of Social Support and Loneliness with Symptoms of Depression, Anxiety, and Posttraumatic Stress during the COVID-19 Pandemic: A Meta-Analysis
Gabarrell‐Pascuet, A., García‐Mieres, H., Giné-Vázquez, I., Moneta, M. V., Koyanagi, A., Haro, J. M., & Domènech‐Abella, J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042765 · Cited by 97
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients
Squassina, A., Costa, M. F., Congiu, D., Manchia, M., Angius, A., Deiana, V., Ardau, R., Chillotti, C., Severino, G., Calza, S., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.004 · Cited by 80
“[1] Waraich P, Goldner EM, Somers JM, Hsu L.”
Background
PHQ-8 Days: a measurement option for DSM-5 Major Depressive Disorder (MDD) severity
Dhingra, S. S., Kroenke, K., Zack, M. M., Strine, T. W., & Balluz, L. S. (2011) · Population Health Metrics · doi:10.1186/1478-7954-9-11 · Cited by 80
“2%, based on the cut-point of 55 days or more and from the DSM-based PHQ-8 algorithm, respectively, are in close proximity to prevalence rates of past 30-day major depression found in other studies and in a systematic review of the literature [19-21].”
Result
Biological vulnerability to depression: linked structural and functional brain network findings
Nixon, N. L., Liddle, P. F., Nixon, E., Worwood, G., Mario Liotti, A., & Palaniyappan, L. K. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.129965 · Cited by 80
Predictors of Incident Depression in Systemic Lupus Erythematosus
Huang, X., Magder, L. S., & Petri, M. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.140111 · Cited by 75
“Patients 1609 (100) Sex Female 1486 (92) Male 123 (8) Ethnicity White 823 (51) African-American 663 (41) East Asian 63 (4) Other 60 (4) Age at cohort entry, yrs < 30 585 (36) 30–44 642 (40) 45–59 305 (19) 60+ 77 (5) Education < High school 150 (10) High school 404 (26) Some college 437 (28) College graduate+ 563 (36)…”
Prediction and prevention of suicide in patients with unipolar depression and anxiety
Gonda, X., Fountoulakis, K. Ν., Kaprinis, G., & Rihmer, Z. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-23 · Cited by 79
Steroid secretion in healthy aging
Fiacco, S., Walther, A., & Ehlert, U. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.035 · Cited by 71
Biological Markers in Noninvasive Brain Stimulation Trials in Major Depressive Disorder
Fidalgo, T. M., Morales-Quezada, J. L., Muzy, G. D. S. C., Chiavetta, N. M., de Mendonça, M. E., Santana, M. V., Gonçalves, Ó. F., Brunoni, A. R., & Fregni, F. (2013) · Journal of Ect · doi:10.1097/yct.0b013e31828b34d8 · Cited by 74
Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness
Sin, J., Spain, D., Furuta, M., Murrells, T., & Norman, I. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011464.pub2 · Cited by 77
Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause
Słopień, R., Pluchino, N., Warenik-Szymankiewicz, A., Sajdak, S., Luisi, M., Drakopoulos, P., & Genazzani, A. R. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1371129 · Cited by 70
“The binding site and mechanism of action involved in allopregnanolone-induced potentiation and activation of the GABAA receptor complex in mature neurons are well-known and lead to an influx of chloride (Cl) that hyperpolarizes neurons and modulates their excitability [7,8].”
Background
Effectiveness of a Smartphone App With a Wearable Activity Tracker in Preventing the Recurrence of Mood Disorders: Prospective Case-Control Study (Preprint)
Cho, C.-H., Lee, T., Lee, J.-B., Seo, J. Y., Jee, H.-J., Son, S., An, H., Kim, L., & Lee, H.-J. (2020) · doi:10.2196/preprints.21283 · Cited by 69
“Mood disorders, including major depressive disorder and bipolar disorder, are prevalent throughout a person's life [1,2].”
Background
Prevalence of depression and anxiety in rheumatoid arthritis patients and their associations with serum vitamin D level
Pu, D., Luo, J., Wang, Y., Ju, B., Lv, X., Fan, P., & He, L. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3874-4 · Cited by 69
“0%, reported in the general population [5].”
International comparison of clinicians' ability to identify depression in primary care: meta-analysis and meta-regression of predictors
Mitchell, A. J., Rao, S., & Vaze, A. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x556227 · Cited by 73
Influence of religion and supernatural beliefs on clinical manifestation and treatment practices in patients with bipolar disorder
Grover, S., Hazari, N., Aneja, J., Chakrabarti, S., & Avasthi, A. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2016.1151930 · Cited by 68
Emotional and cognitive changes in chronic kidney disease
Kim, D., Kim, S.-W., & Gil, H. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.492 · Cited by 70
“Depression is also common in the general population, with a lifetime risk of about 7% [22].”
Background
GPR56/ADGRG1 is associated with response to antidepressant treatment
Belzeaux-R, R., Gorgievski, V., Fiori, L. M., López, J. P., Grenier, J., Lin, R., Nagy, C., Ibrahim, E. C., Gascon, E., Courtet, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15423-5 · Cited by 70
Marital therapy for depression
Barbato, A., & D'Avanzo, B. B. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004188.pub2 · Cited by 70
Cognitive impairment in patients with rheumatoid arthritis
Vitturi, B. K., Nascimento, B. A. C., Alves, B. R., de Campos, F. S. C., & Torigoe, D. Y. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.08.027 · Cited by 64
A comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis
Jiménez-Labaig, P., Aymerich, C., Braña, I., Rullan, A., Cacicedo, J., Torres, M. Á. G., Harrington, K. J., & Catalán, A. (2024) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkae031 · Cited by 72
Increased peripheral blood expression of electron transport chain genes in bipolar depression
Beech, R. D., Lowthert, L., Leffert, J. J., Mason, P. N., Taylor, M. M., Umlauf, S., Lin, A., Lee, J. Y., Maloney, K. H., Muralidharan, A., et al. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00882.x · Cited by 63
Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression
Barrera, I., & Spiegel, D. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864259 · Cited by 75
Update of recent literature on remotely delivered psychotherapy interventions for anxiety and depression
Lamb, T., Pachana, N. A., & Dissanayaka, N. (2019) · Telemedicine and e-Health · doi:10.1089/tmj.2018.0079 · Cited by 55
Depression in late adolescence: a cross-sectional study in senior high schools in Greece
Magklara, K., Bellos, S., Niakas, D. A., Stylianidis, S., Kolaitis, G. A., Mavreas, V. G., & Skapinakis, P. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0584-9 · Cited by 59
“Cannabis use and depression are presented commonly as comorbid conditions in clinical and community populations [47, 48].”
Background
Folate Augmentation of Treatment – Evaluation for Depression (FolATED): randomised trial and economic evaluation
Bedson, E., Bell, D., Carr, D. F., Carter, B., Hughes, D. A., Jorgensen, A., Lewis, H., Lloyd, K. R., McCaddon, A., Moat, S. J., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18480 · Cited by 63
Prevalence of major depressive disorder and socio-demographic correlates: Results of a representative household epidemiological survey in Beijing, China
Liu, J., Yan, F., Ma, X., Guo, H.-L., Tang, Y., Rakofsky, J. J., Wu, X., Li, X., Zhu, H., Guo, X., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.009 · Cited by 62
“Our survey indicated that females suffered from MDD twice as often as males, which is consistent with most of the previous studies across different cultures and populations (Kuehner, 2003; Waraich et al., 2004).”
Result
Performance of Screening Tools in Detecting Major Depressive Disorder among Patients with Coronary Heart Disease: A Systematic Review
Liu, M. (2015) · Medical Science Monitor · doi:10.12659/msm.892537 · Cited by 58
Under-diagnosis of mood disorders in Canada
Pelletier, L., O'Donnell, S., Dykxhoorn, J., McRae, L., & Patten, S. B. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000329 · Cited by 57
“Similar global annual prevalence estimates have also been reported (Waraich et al. 2004; Ferrari et al. 2011, 2013; Merikangas et al. 2011).”
Background
Evaluating the efficacy and cost-effectiveness of web-based indicated prevention of major depression: design of a randomised controlled trial
Buntrock, C., Ebert, D. D., Lehr, D., Cuijpers, P. J., Riper, H. M., Smit, F., & Berking, M. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-25 · Cited by 60
“Major depressive disorder (MDD) is highly prevalent [1,2] and has an incidence rate that is high relative to the number of prevalent cases [3].”
Background
Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation
Lowthert, L., Leffert, J. J., Lin, A., Umlauf, S., Maloney, K. H., Muralidharan, A., Lorberg, B. A., Mane, S., Zhao, H., Sinha, R., et al. (2012) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-2-15 · Cited by 58
Gender differences in subtypes of depression by first incidence and age of onset: a follow-up of the Lundby population
Bogren, M., Brådvik, L., Holmstrand, C., Nöbbelin, L., & Mattisson, C. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0778-x · Cited by 57
“Some of the other studies may have overestimated the first incidence rates due to recall bias, leading to underreporting of previous episodes [13, 33], or the use of structured assessments by lay interviewers may have led to artefactual inclusion of common sadness or situational unhappiness [34].”
BackgroundResultInfluential
The Prevalence of Mood and Anxiety Disorders in Australian Women
Williams, L. J., Jacka, F. N., Pasco, J. A., Henry, M. J., Dodd, S., Nicholson, G. C., Kotowicz, M. A., & Berk, M. (2010) · Australasian Psychiatry · doi:10.3109/10398561003731155 · Cited by 57
Mindfulness and progressive muscle relaxation as standardized session‐introduction in individual therapy: A randomized controlled trial
Mander, J., Blanck, P., Neubauer, A. B., Kröger, P., Flückiger, C., Lutz, W., Barnow, S., Bents, H., & Heidenreich, T. (2019) · Journal of Clinical Psychology · doi:10.1002/jclp.22695 · Cited by 56
The development and psychometric properties of a measure of clinicians’ attitudes to depression: the revised Depression Attitude Questionnaire (R-DAQ)
Haddad, M., Menchetti, M., McKeown, E., Tylee, A. T., & MANN, A. H. (2015) · BMC Psychiatry · doi:10.1186/s12888-014-0381-x · Cited by 63
“Depression is one of the most common mental disorders, affecting an estimated 350 million people worldwide [1] and with a 12-month community prevalence of 4% to 7% [2].”
Background
A moderate-sodium DASH-type diet improves mood in postmenopausal women
Torres, S. J., & Nowson, C. A. (2012) · Nutrition · doi:10.1016/j.nut.2011.11.029 · Cited by 58
Changes in rates of recorded depression in English primary care 2003–2013: Time trend analyses of effects of the economic recession, and the GP contract quality outcomes framework (QOF)
Kendrick, T., Stuart, B. L., Newell, C., Geraghty, A. W. A., & Moore, M. V. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.040 · Cited by 55
The Prevalence and Incidence of Treated Major Depressive Disorder among National Health Insurance Enrollees in Taiwan, 1996 to 2003
Chien, I., Kuo, C.-C., Bih, S., Chou, Y., Lin, C., Lee, C., & Chou, P. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200106 · Cited by 54
Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study
Maneeton, N., Maneeton, B., & Louthrenoo, W. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s44248 · Cited by 54
“3%, respectively.(1) The high morbidity of depression in SLE warrants continuing research and expansion of efforts in the clinical setting to optimize treatments.”
The Impact of Targeted Rheumatoid Arthritis Pharmacologic Treatment on Mental Health
Matcham, F., Galloway, J. B., Hotopf, M. H., Roberts, E., Scott, I. C., Steer, S. E., & Norton, S. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40565 · Cited by 58
“These estimates are substantially higher than those in the general population, in which estimates of the prevalence of depression are typically ~5% (5).”
Background
A population-based analysis of distinguishers of bipolar disorder from major depressive disorder
Schaffer, A., Cairney, J., Veldhuizen, S., Kurdyak, P., Cheung, A., & Levitt, A. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.118 · Cited by 53
“Other large epidemiological surveys have reported prevalence rates for BD and MDD by age, gender, or both; however sociodemographic variableswere not directly compared across diagnoses, and the independent roles of these variables as possible distinguishers of BD could not be ascertained due to the lackof adjustment f…”
Background
Psychotic features in bipolar and unipolar depression
Goes, F. S., Sadler, B., Toolan, J., Zamoiski, R. D., Mondimore, F. M., MacKinnon, D. F., Schweizer, B. W., The Bipolar Disorder Phenome Group, DePaulo, J. R., & Potash, J. B. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00460.x · Cited by 53
Molecular epidemiology of major depressive disorder
Kiyohara, C., & Yoshimasu, K. (2009) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-008-0073-6 · Cited by 53
“Ethnicity is a neglected dimension of the heterogeneity of the black population [51].”
Background
Short-Term Effects of a Web-Based Guided Self-Help Intervention for Employees With Depressive Symptoms: Randomized Controlled Trial
Geraedts, A. S., Kleiboer, A. M., Wiezer, N. M., van Mechelen, W., & Cuijpers, P. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3185 · Cited by 48
“Depressive disorders are highly prevalent in the general [1-3] and working [4,5] population and lead to excessive costs [6,7].”
Background
Major Depression Prevalence is Very High, but the Syndrome is a Poor Proxy for Community Populations' Clinical Treatment Needs
Patten, S. B. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300702 · Cited by 52
Risperidone
Fenton, C., & Scott, L. J. (2005) · CNS Drugs · doi:10.2165/00023210-200519050-00005 · Cited by 52
Aripiprazole alone or in combination for acute mania
Brown, R., Taylor, M. J., & Geddes, J. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005000.pub2 · Cited by 52
A Systematic Review and Meta-Analysis of Depression and Protein–Energy Wasting in Kidney Disease
Gregg, L. P., Carmody, T. J., Le, D., Martins, G., Trivedi, M. H., & Hedayati, S. S. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.12.009 · Cited by 55
Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials
Maneeton, N., Maneeton, B., Srisurapanont, M., & Martin, S. D. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-160 · Cited by 51
Low-dose oral isotretinoin versus topical retinoic acid for photoaging: A randomized, comparative study
Bagatin, E., Guadanhim, L. R. S., Enokihara, M. M. S. S., Sanudo, A., Talarico, S., Miot, H. A., & Gibson, L. (2014) · International Journal of Dermatology · doi:10.1111/ijd.12191 · Cited by 52
Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders
Chen, S., Jiang, H., Liu, Y., Hou, Z., Yue, Y., Zhang, Y., Zhao, F., Xu, Z., Li, Y., Mou, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06832-6 · Cited by 50
Non-Synonymous Single Nucleotide Polymorphisms in the P2X Receptor Genes: Association with Diseases, Impact on Receptor Functions and Potential Use as Diagnosis Biomarkers
Caseley, E. A., Muench, S. P., Roger, S., Mao, H., Baldwin, S. A., & Jiang, L. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150813344 · Cited by 54
Methodology and reporting of systematic reviews and meta-analyses of observational studies in psychiatric epidemiology: Systematic review
Brugha, T. S., Matthews, R. J., Morgan, Z., Hill, T., Alonso, J., & Jones, D. R. H. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.098103 · Cited by 51
Association between physical limitations and depressive symptoms among Indian elderly: marital status as a moderator
Hossain, B., Yadav, P. K., Nagargoje, V. P., & Joseph, V. J. K. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03587-3 · Cited by 50
Retinoids for prevention and treatment of actinic keratosis
Ianhez, M., Fleury, L. F. F., Miot, H. A., & Bagatin, E. (2013) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20131803 · Cited by 49
Depression requiring anti-depressant drug therapy in adult congenital heart disease: prevalence, risk factors, and prognostic value
Diller, G., Bräutigam, A., Kempny, A., Uebing, A. S., Alonso-González, R., Swan, L., Babu‐Narayan, S. V., Baumgartner, H., Dimopoulos, K., & Gatzoulis, M. Α. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv386 · Cited by 48
The Prevalence of Electroconvulsive Therapy Use Since 1973
LESAGE, A. D., Lemasson, M., Medina, K. A. Q., Tsopmo, J., Sebti, N., Potvin, S., & Patry, S. (2016) · Journal of Ect · doi:10.1097/yct.0000000000000320 · Cited by 50
The correlations of socioeconomic status, disease activity, quality of life, and depression/anxiety in Chinese patients with rheumatoid arthritis
Zhang, L., Xia, Y., Zhang, Q., Fu, T., Yin, R., Guo, G., Li, L., & Gu, Z. (2016) · Psychology Health & Medicine · doi:10.1080/13548506.2016.1198817 · Cited by 48
Couple therapy for depression
Barbato, A., D’Avanzo, B., & Parabiaghi, A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004188.pub3 · Cited by 50
Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease
Romejko, K., Rymarz, A., Sadownik, H., & Niemczyk, S. (2022) · Nutrients · doi:10.3390/nu14163438 · Cited by 52
Prevalence of gastroesophageal reflux disease in major depressive disorder: a population-based study.
Chou, P.-H., Lin, C.-C., Lin, C.-H., Tsai, C., Cheng, C., Chuo, Y.-P., Chan, C.-H., & Lan, T.-H. (2014) · Psychosomatics · doi:10.1016/j.psym.2013.06.003 · Cited by 45
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer
Okamura, M., Akizuki, N., Nakano, T., Shimizu, K., Ito, T., Akechi, T., & Uchitomi, Y. (2008) · Psycho-Oncology · doi:10.1002/pon.1213 · Cited by 46
“Although the prevalence of major depressive disorder in the community is 3–4% [1], it rises to 5–26% in advanced cancer patients [2].”
Background
Rheumatoid Arthritis: Are psychological factors effective in disease flare?
Yılmaz, V., Umay, E., Gündoğdu, İ., Karaahmet, Ö. Z., & Ozturk, A. E. (2017) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2017.16100 · Cited by 46
“8% prevalence of depression (2), while the estimated prevalence in general population is 5% (3).”
Background
Recent developments in the epidemiology of bipolar disorder in adults and children: Magnitude, correlates, and future directions.
Merikangas, K. R., & Pato, M. (2009) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.2009.01152.x · Cited by 49
“Waraich et al. (2004) showed that there was remarkable stability in the lifetime prevalence of bipolar disorder across adulthood, thereby demonstrating the chronicity of this condition across the lifespan.”
BackgroundMethod
Does anxiety increase impulsivity in patients with bipolar disorder or major depressive disorder?
Bellani, M., Hatch, J. P., Nicoletti, M., Ertola, A. E., Zunta‐Soares, G. B., Swann, A. C., Brambilla, P., & Soares, J. C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.016 · Cited by 50
Prevalence of Bipolar I and II Disorder in Canada
McDonald, K. C., Bulloch, A. G. M., Duffy, A., Bresee, L., Williams, J. V. A., Lavorato, D. H., & Patten, S. B. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000310 · Cited by 45
C-reactive protein and depression in persons with Human Immunodeficiency Virus infection: The Positive Living with HIV (POLH) Study
Poudel‐Tandukar, K., Bertone‐Johnson, E. R., Palmer, P. H., & Poudel, K. C. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.004 · Cited by 45
Systematic review of the prevalence of bipolar disorder and bipolar spectrum disorders in population-based studies
Júnior, J. C. D., Basso, L. A., Argimon, I. I. D. L., & Arteche, A. X. (2013) · Trends in Psychiatry and Psychotherapy · doi:10.1590/s2237-60892013000200002 · Cited by 46
Cognition and Aging in Psychopathology: Focus on Schizophrenia and Depression
Harvey, P. D., Reichenberg, A., & Bowie, C. R. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095206 · Cited by 44
The epidemiological modelling of dysthymia: Application for the Global Burden of Disease Study 2010
Charlson, F. J., Ferrari, A. J., Flaxman, A. D., & Whiteford, H. A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.060 · Cited by 44
Indirect prevention and treatment of depression: an emerging paradigm?
Cuijpers, P. (2021) · Clinical Psychology in Europe · doi:10.32872/cpe.6847 · Cited by 44
“, 2004; Kessler & Bromet, 2013), have a high incidence (Waraich et al., 2004), and are associated with a substantial loss of quality of life for patients and their relatives (Saarni et al.”
Background
Use of benzodiazepine and risk of cancer: A meta-analysis of observational studies
Kim, H.-B., Myung, S., Park, Y. C., & Park, B. (2016) · International Journal of Cancer · doi:10.1002/ijc.30443 · Cited by 43
Comorbidities are Frequent in Patients with Gastroesophageal Reflux Disease in a Tertiary Health Care Hospital
Moraes-Filho, J. P. P., Navarro-Rodríguez, T., Eisig, J. N., Barbuti, R. C., Chinzon, D., & Quigley, E. M. M. (2009) · Clinics · doi:10.1590/s1807-59322009000800013 · Cited by 43
Higher prevalence of major depressive symptoms in Brazilians aged 14 and older
Coelho, C. L. D. S., Crippa, J. A. S., Santos, J. L. F., Pinsky, I., Zaleski, M., Caetano, R., & Laranjeira, R. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2012-0875 · Cited by 42
Heterogeneity of sleep quality in relation to circadian preferences and depressive symptomatology among major depressive patients
Selvı, Y., Boysan, M., Kandeğer, A., Uygur, Ö. F., Sayin, A. A., Akbaba, N., & Koc, B. O. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.018 · Cited by 44
Psychiatric comorbidities and adverse childhood experiences in women with self-reported polycystic ovary syndrome: An Australian population-based study
Tay, C. T., Teede, H. J., Loxton, D. J., Kulkarni, J., & Joham, A. E. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104678 · Cited by 42
Parallel Journeys of Patients with Cancer and Depression: Challenges and Opportunities for Technology-Enabled Collaborative Care
Suh, J., Williams, S., Fann, J. R., Fogarty, J. A., Bauer, A. M., & Hsieh, G. (2020) · Proceedings of the ACM on Human-Computer Interaction · doi:10.1145/3392843 · Cited by 42
“Recent meta-analyses have found the prevalence of depression in patients with cancer to be as high as 24% [68, 94], much higher than the 8% annual prevalence in the general population [119, 128].”
Background
Clinical features of psychogenic non-epileptic seizures in prepubertal and pubertal patients with idiopathic epilepsy
Verrotti, A., Agostinelli, S., Mohn, A., Manco, R., Coppola, G., Franzonı, E., Cerminara, C., Parisi, P., Iannetti, P., Spalice, A., et al. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0107-x · Cited by 40
“In the general population, the prevalence of major depressive disorders in these age groups is approximately 2–5% [26, 27].”
Background
Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors
Korszun, A., Sarker, S., Chowdhury, K., Clark, C., Greaves, P., Johnson, R., Kingston, J. E., Levitt, G., Matthews, J., White, P. D., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12698 · Cited by 40
“In our group of survivors, 24 3% reported a previous history of depression, which is higher than the lifetime prevalence of depressive disorders reported for the general population both in Europe [6 7% (Waraich et al, 2004)] and in USA [16 2% (Kessler et al, 2005)].”
Result
Sudarshan Kriya Yoga improves cardiac autonomic control in patients with anxiety-depression disorders
Toschi‐Dias, E., Tobaldini, E., Solbiati, M., Costantino, G., Sanlorenzo, R., Doria, S., Irtelli, F., Mencacci, C., & Montano, N. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.017 · Cited by 42
“Besides being common lifelong, affective spectrum disorders are some of the most burdensome diseases with respect to their global impact on morbidity, mortality, and loss of quality of life (Baxter et al., 2013; De Wilde et al., 2007; Pavlova et al., 2015; Waraich et al., 2004).”
Background
Utility scores for different health states related to depression: individual participant data analysis
Kolovos, S., Bosmans, J. E., van Dongen, J. M., van Esveld, B., Magai, D. N., van Straten, A., Feltz-Cornelis, C. M. V. D., van Steenbergen-Weijenburg, K. M., Huijbregts, K. M. L., van Marwijk, H., et al. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1536-2 · Cited by 40
Metyrapone in treatment-resistant depression
Sigalas, P. D., Garg, H., Watson, S., McAllister-Williams, H., & Ferrier, I. N. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312436597 · Cited by 40
“It has been reported to have a 1-year prevalence of 3–5% [Hasin et al. 2005; Waraich et al. 2004] and a lifetime prevalence varying from 10 to 30% [Hasin et al. 2005; Waraich et al. 2004].”
Background
Work impairment in bipolar disorder patients – results from a two-year observational study (EMBLEM)
Reed, C. C., GOETZ, I. A., Vieta, E., Bassi, M., Haro, J. M., & the EMBLEM Advisory Board (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2010.01.001 · Cited by 44
Environmental and individual characteristics associated with depressive disorders and mental health care use
Annequin, M., Weill, A., Thomas, F., & Chaix, B. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.02.002 · Cited by 39
“Studies have shown how individual sociodemographic factors are associated with depression and use of mental health services [1-3].”
The prevalence of depression in rheumatoid arthritis in China: A systematic review
Fu, X., Li, Z., Yang, C.-J., Feng, L., Sun, L., Yao, Y., & Huang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17323 · Cited by 39
“5% [2], higher than the general population [3], even higher than www.”
Background
The prevalence and socioeconomic correlates of depressive and anxiety symptoms in a group of 1,940 Serbian university students
Simić-Vukomanović, I., Mihajlović, G., Kocic, S. S., Djonović, N., Banković, D., Vukomanović, V., & Djukić, A. (2015) · Vojnosanitetski pregled · doi:10.2298/vsp141106143s · Cited by 38
“Bratisl Lek Listy 2008; 109(12): 568−72.”
Diagnosis and treatment in the early illness phase of bipolar disorders
Bauer, M., Juckel, G., Correll, C. U., Leopold, K., & Pfennig, A. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-008-5009-z · Cited by 39
Early Detection and Intervention in Bipolar Affective Disorder: Targeting the Development of the Disorder
Howes, O. D., & Falkenberg, I. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0229-8 · Cited by 37
A study on mental disorders: 5-year retrospective study
Celine, T., & Antony, J. (2014) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.130260 · Cited by 39
“8% for bipolar I disorder.[22] In the United States it was 20.”
Background
Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials
Huang, K., Lu, W., Wang, Y.-Y., Hu, G., Lu, C.-H., Lee, W., & Hsu, C. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414525837 · Cited by 36
“The global lifetime prevalence of major depressive disorder (MDD) is an estimated 6.7% (Waraich et al., 2004).”
BackgroundInfluential
The influence of comorbid chronic physical conditions on depression recognition in primary care: A systematic review
Menear, M., Doré, I., Cloutier, A., Perrier, L., Roberge, P., Duhoux, A., Houle, J., & Fournier, L. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.11.016 · Cited by 35
Psychotrichology: psychosomatic aspects of hair diseases
Harth, W., & Blume‐Peytavi, U. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.08034.x · Cited by 36
GET.ON Mood Enhancer: efficacy of Internet-based guided self-help compared to psychoeducation for depression: an investigator-blinded randomised controlled trial
Ebert, D. D., Lehr, D., Baumeister, H., Boß, L., Riper, H. M., Cuijpers, P. J., Reins, J. A., Buntrock, C., & Berking, M. (2014) · Trials · doi:10.1186/1745-6215-15-39 · Cited by 37
“Major depressive disorder (MDD) is one of the most prevalent psychiatric disorders with a lifetime prevalence of more than 16% [1-3].”
Background
Life negative events and depressive symptoms: the China longitudinal ageing social survey
Wang, Z., Yang, H., Zheng, P., Liu, B., Guo, Z., Geng, S., & Hong, S. (2020) · BMC Public Health · doi:10.1186/s12889-020-09119-0 · Cited by 39
Environmental manipulation affects depressive-like behaviours in female Wistar-Kyoto rats
Mileva, G. R., & Bielajew, C. H. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.035 · Cited by 37
“Depression is one of the most prevalent mental health disorders in the world today and places an enormous burden on the economy and healthcare systems worldwide [13,33,64].”

Authors: Waraich, P., Goldner, E. M., Somers, J. M., & Hsu, L.
Affiliations: University of British Columbia (CA)
Corresponding author: Waraich, Paul
ORCID: Somers, Julian M
Venue: The Canadian Journal of Psychiatry
Publisher: SAGE Publications
Published: 2004-02
Volume: 49
Issue: 2
Pages: 124-138
ISSN: 0706-7437 (ISSN-L)
1497-0015
DOI: 10.1177/070674370404900208
OpenAlex: W4237251694
Cited by: 522
References: 83
Citations by year: 2026: 6 · 2025: 13 · 2024: 21 · 2023: 21 · 2022: 28 · 2021: 26 · 2020: 16 · 2019: 27 · 2018: 29 · 2017: 31 · 2016: 31 · 2015: 33 · 2014: 39 · 2013: 39 · 2012: 29
FWCI: 1.77
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: The Canadian Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: Ministry of Health, British Columbia
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: mood disorders, prevalence, incidence, major depressive disorder, dysthymia, bipolar I disorder, primary care, lifetime prevalence, methodological heterogeneity
MeSH terms: Analysis of Variance, Bipolar Disorder, Cross-Sectional Studies, Cross-Cultural Comparison, Major Depressive Disorder, Depressive Disorder, Major, Humans, Incidence, Dysthymic Disorder, Mood Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks